APA (7th ed.) Citation

Thimmulappa, R. K., Fuchs, R. J., Malhotra, D., Scollick, C., Traore, K., Bream, J. H., . . . Biswal, S. (2007). Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils. Antioxidants & redox signaling, 9(11), 1963. https://doi.org/10.1089/ars.2007.1745

Chicago Style (17th ed.) Citation

Thimmulappa, Rajesh K., et al. "Preclinical Evaluation of Targeting the Nrf2 Pathway by Triterpenoids (CDDO-Im and CDDO-Me) for Protection from LPS-induced Inflammatory Response and Reactive Oxygen Species in Human Peripheral Blood Mononuclear Cells and Neutrophils." Antioxidants & Redox Signaling 9, no. 11 (2007): 1963. https://doi.org/10.1089/ars.2007.1745.

MLA (9th ed.) Citation

Thimmulappa, Rajesh K., et al. "Preclinical Evaluation of Targeting the Nrf2 Pathway by Triterpenoids (CDDO-Im and CDDO-Me) for Protection from LPS-induced Inflammatory Response and Reactive Oxygen Species in Human Peripheral Blood Mononuclear Cells and Neutrophils." Antioxidants & Redox Signaling, vol. 9, no. 11, 2007, p. 1963, https://doi.org/10.1089/ars.2007.1745.